PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28857200-0	2017	By inhibiting PFKFB3, aspirin overcomes sorafenib resistance in hepatocellular carcinoma.	Aspirin	22-29	6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3	Mus musculus	14-20	
28857200-5	2017	High glycolysis and PFKFB3 overexpression occupied a dominant position in sorafenib resistance, and can be targeted and overcome by aspirin.	Aspirin	132-139	6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3	Mus musculus	20-26